series-a
Stage
1
Investors
About
Tectonic Therapeutic is a clinical-stage biotechnology company focused on discovering and developing therapeutic proteins and antibodies targeting G-Protein Coupled Receptors (GPCRs) using their proprietary GEODe™ platform.
Explore Tectonic Therapeutic's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.